CVS HEALTH REPORTS STRONG SECOND QUARTER RESULTS, RAISES 2022 FULL-YEAR EPS AND CASH FLOW FROM OPERATIONS GUIDANCE

Go back to CVS HEALTH REPORTS STRONG SECOND QUARTER RESULTS, RAISES 2022 FULL-YEAR EPS AND CASH FLOW FROM OPERATIONS GUIDANCE
CVS Caremark Corp. (NYSE: CVS) Delayed: 93.95 -0.8 (0.84%)
Previous Close $94.75    52 Week High $106.67 
Open $95.26    52 Week Low $69.30 
Day High $95.26    P/E 25.05 
Day Low $93.72    EPS $3.75 
Volume 3,432,134